Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ishihara Sangyo Kaisha,Ltd. (4028.T)
Osaka, JP
Ishihara Sangyo Kaisha, Ltd. is a global producer and distributor of both organic and inorganic chemicals, with its operations spanning Japan, Asia, the United States, Europe, and other international markets. A key segment of its product line consists of TIPAQUE brand titanium dioxide (TiO2) offerings. These encompass white pigments, widely utilized in the production of items such as paints, inks, plastics, and paper, alongside yellow pigments. Additionally, the company provides an array of functional materials, including ultrafine TiO2, ultrafine ZnO, electro-conductive substances, photocatalytic TiO2, high-purity TiO2, titanium tetrachloride, TiO2 for catalytic applications, acicular TiO2, glass coatings, and battery components. Its broader chemical portfolio also features matting agents, heat-shielding substances, and various agrochemicals like herbicides, fungicides, insecticides, and nematicides. Furthermore, Ishihara Sangyo supplies animal healthcare products, pharmaceutical reagents, and CF3-Pyridine organic intermediates specifically for pharmaceutical research. The company, which maintains its corporate headquarters in Osaka, Japan, was established in 1920.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.26% | -13.38% | -3.84% | -15.65% | +2.71% | -1.05% | +53.97% | +111.53% | +165.08% | +254.94% | +33.97% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+6.7% ★ Q1'26: +17.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+97.7% ★ Q1'26: +6.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+5.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.3% ★ Q1'26: +17.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+9.2% ★ Q1'26: +16.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.96× Q1'26: 1.88× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 2 Rev. Ana. 2 EPS Ana. |
Mar 2027 3 Rev. Ana. 3 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
108.00B
est: 107.00B (+0.9%)
|
106.44B
est: 110.00B (-3.2%)
|
101.07B
est: 100.50B (+0.6%)
|
101.77B
est: 100.00B (+1.8%)
|
110.96B
est: 110.00B (+0.9%)
|
131.24B
est: 132.00B (-0.6%)
|
138.46B
est: 138.44B (+0.0%)
|
145.20B
est: 147.80B (-1.8%)
|
153.70B
152.90B – 154.50B
+4.0% YoY
|
157.05B
151.18B – 162.58B
+2.2% YoY
|
156.95B
156.11B – 157.79B
-0.1% YoY
|
| EBITDA |
11.88B
est: 12.78B (-7.0%)
|
16.00B
est: 13.14B (+21.8%)
|
11.05B
est: 12.00B (-8.0%)
|
10.68B
est: 11.94B (-10.5%)
|
16.21B
est: 13.14B (+23.4%)
|
13.97B
est: 15.76B (-11.4%)
|
17.48B
est: 22.89B (-23.6%)
|
16.23B
est: 24.44B (-33.6%)
|
25.41B
25.28B – 25.54B
+4.0% YoY
|
25.96B
24.99B – 26.88B
+2.2% YoY
|
25.95B
25.81B – 26.09B
-0.1% YoY
|
| EBIT |
7.24B
est: 8.28B (-12.6%)
|
11.37B
est: 8.51B (+33.6%)
|
6.19B
est: 7.78B (-20.4%)
|
5.63B
est: 7.74B (-27.2%)
|
11.56B
est: 8.51B (+35.8%)
|
8.63B
est: 10.21B (-15.5%)
|
12.17B
est: 20.04B (-39.3%)
|
10.48B
est: 21.39B (-51.0%)
|
22.24B
22.13B – 22.36B
+4.0% YoY
|
22.73B
21.88B – 23.53B
+2.2% YoY
|
22.71B
22.59B – 22.84B
-0.1% YoY
|
| Net Income |
3.44B
est: 7.17B (-52.0%)
|
8.68B
est: 7.46B (+16.3%)
|
2.36B
est: 1.43B (+64.5%)
|
3.37B
est: 1.24B (+171.4%)
|
11.69B
est: 6.22B (+87.9%)
|
6.95B
est: 5.23B (+32.9%)
|
7.99B
est: 5.88B (+36.0%)
|
8.41B
est: 7.29B (+15.4%)
|
12.98B
12.37B – 13.59B
+78.0% YoY
|
11.93B
10.81B – 14.58B
-8.1% YoY
|
14.01B
11.96B – 18.58B
+17.4% YoY
|
| SGA |
17.04B
est: 16.06B (+6.1%)
|
17.92B
est: 16.51B (+8.6%)
|
17.95B
est: 15.08B (+19.0%)
|
16.25B
est: 15.01B (+8.3%)
|
14.36B
est: 16.51B (-13.0%)
|
17.30B
est: 19.81B (-12.6%)
|
17.91B
est: 20.07B (-10.8%)
|
19.88B
est: 21.43B (-7.2%)
|
22.29B
22.17B – 22.40B
+4.0% YoY
|
22.77B
21.92B – 23.57B
+2.2% YoY
|
22.76B
22.64B – 22.88B
-0.1% YoY
|
| EPS |
86.11
est: 187.60 (-54.1%)
|
217.25
est: 195.20 (+11.3%)
|
59.03
est: 37.50 (+57.4%)
|
84.41
est: 32.50 (+159.7%)
|
292.59
est: 162.70 (+79.8%)
|
175.73
est: 137.20 (+28.1%)
|
209.26
est: 153.87 (+36.0%)
|
219.97
est: 190.80 (+15.3%)
|
339.70
323.18 – 355.26
+78.0% YoY
|
336.95
282.51 – 380.97
-0.8% YoY
|
409.20
312.69 – 485.52
+21.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.19% | 746.9K | 0.58% |
| 2 | JPMorgan International Value ETF JIVE | 0.15% | 4.71M | 0.55% |
| 3 | Dimensional - International Small Cap Value ETF DISV | 0.09% | 4.29M | 0.42% |
| 4 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.07% | 290.9K | 0.48% |
| 5 | Avantis International Small Cap Value ETF AVDV | 0.07% | 12.75M | 0.36% |
| 6 | iShares International Developed Small Cap Value Factor ETF ISVL | 0.07% | 212.4K | 0.31% |
| 7 | WisdomTree International SmallCap Dividend Fund DLS | 0.06% | 673.1K | 0.58% |
| 8 | WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc DXJD.SW | 0.06% | 578.9K | 0.45% |
| 9 | WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc DXJF.MI | 0.06% | 534.2K | 0.45% |
| 10 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.06% | 468.9K | 0.48% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihiko Kikuchi | Director of Legal & IP Headquarters & Executive Officer | — | — |
| Hiroshi Okubo | President, Chief Compliance Officer & Director | — | male |
| Kenji Tanaka | Managing Executive Officer & Director of Corporate Administration and Planning Headquarters | — | male |
| Makiko Sano | Executive Officer & Executive Director of Office of Sustainability Promotion | — | — |
| Mikiya Horie | Senior Managing Executive Officer, Head of Bioscience Business Division & Director | — | male |
| Shigeru Mitani | Exec Director of Office of Environ, Safety and Quality Admin. & Manag. Executive Officer | — | — |
| Toichiro Shiomi | Managing Executive Officer and Director of Finance & Accounting Headquarters | — | — |
| Tooru Sakamoto | Executive Off and Deputy Director of Inorganic Chemicals Business HQ, Procurement, Sales & Marketing | — | — |
| Watanabe Hiroyuki | Managing Executive Officer & Healthcare Business Headquarters | — | — |
| Yoshio Nishiyama | Managing Executive Officer, Director of General Affairs & HR Division and Director | — | male |
| Yoshiyuki Shimmyo | Managing Executive Officer, GM of Inorganic Chemicals Division & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4028.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
